Saba Capital Management’s SBC Medical Group SBC Stock Holding History

Saba Capital Management’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,000	Closed	-$2.15M	–	457
2023 Q4	$2.15M	Hold	200,000	–	–	0.04%	195
2023 Q3	$2.13M	Hold	200,000	–	–	0.05%	207
2023 Q2	$2.06M	Hold	200,000	–	–	0.05%	227
2023 Q1	$2.09M	Hold	200,000	–	–	0.04%	334
2022 Q4	$2.04M	Buy	200,000 +42,457	+27%	+$430K	0.03%	495
2022 Q3	$1.58M	Buy	+157,543	New	+$1.58M	0.02%	651

Other funds holding SBC

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $60.8M AUM 17.47% 1-Year Est. Return

Saba Capital Management's SBC Position: Q1 2024 in Review

Saba Capital Management sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 200,000 shares — an estimated $2.15M sold.

Saba Capital Management first reported a position in SBC in Q3 2022 and held it in 6 quarters. The position peaked at $2.15M in Q4 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

Saba Capital Management reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
Saba Capital Management sold 200,000 SBC Medical Group shares in Q1 2024, an estimated $2.15M.
Saba Capital Management first reported a position in SBC Medical Group in Q3 2022 and held it in 6 quarters.
Saba Capital Management's SBC Medical Group position peaked at $2.15M in Q4 2023.
5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Saba Capital Management's 13F filing for Q1 2024, filed 15 May 2024.